<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250226111405
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250226111405" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Wed, 26 Feb 2025 16:14:06 +0000</lastbuilddate>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Suspected heart failure: a clinical pattern that calls for action</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39999002/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 25:ehae846. doi: 10.1093/eurheartj/ehae846. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39999002/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39999002</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae846>10.1093/eurheartj/ehae846</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39999002</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Stefan Störk</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Suspected heart failure: a clinical pattern that calls for action</dc:title>
<dc:identifier>pmid:39999002</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae846</dc:identifier>
</item>
<item>
<title>Three strikes in a row: a challenging case of carcinoid syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39998470/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 25:ehaf087. doi: 10.1093/eurheartj/ehaf087. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39998470/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39998470</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf087>10.1093/eurheartj/ehaf087</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39998470</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Giuseppe Bruschi</dc:creator>
<dc:creator>Igor Belluschi</dc:creator>
<dc:creator>Claudio F Russo</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Three strikes in a row: a challenging case of carcinoid syndrome</dc:title>
<dc:identifier>pmid:39998470</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf087</dc:identifier>
</item>
<item>
<title>Metabolic flexibility and reverse remodelling of the failing human heart</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39998427/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: CRT acutely alters the metabolic phenotype of non-ischaemic cardiomyopathy towards a more physiological picture of FA uptake which correlates with reverse remodelling. Retained metabolic flexibility may therefore be critical for subsequent reverse remodelling.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 25:ehaf033. doi: 10.1093/eurheartj/ehaf033. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Cardiac resynchronization therapy (CRT) produces long-term reverse remodelling which requires greater adenosine triphosphate delivery to the contractile machinery. Whilst the heart retains some metabolic flexibility in non-ischaemic cardiomyopathy, whether this correlates with reverse remodelling is unknown. This study investigated whether CRT acutely changes cardiac substrate uptake, and whether this translates to favourable reverse remodelling.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The effect of CRT on cardiac substrate uptake was assessed via direct coronary flow and arteriovenous measurements, with metabolomic/lipidomic analysis on infusions of insulin/glucose and intralipid. Cardiac function was assessed with left ventricular pressure-volume loops during implantation, and cardiac magnetic resonance before and 6 months following CRT, with and without biventricular pacing.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Regardless of substrate infusion, CRT acutely improved stroke work without increasing O2 uptake on both insulin/glucose (by 34%, P = .05) and intralipid (by 36%, P = .03). This was followed by increased fatty acid (FA) uptake on insulin/glucose (R = 0.89, P = .03) and increased β-hydroxybutyrate uptake (R = 0.81, P = .05) during intralipid infusion. After 6 months, there was a 48% (P &lt; .001) reduction in left ventricular end diastolic volume, beyond that achievable by acutely shortening or lengthening QRS duration. Reverse remodelling significantly correlated with increased FA uptake with CRT on insulin/glucose (R = 0.71, P = .05) driven by long and medium chain uptake, and increased ketone uptake with CRT on intralipid (R = 0.79, P = .05).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: CRT acutely alters the metabolic phenotype of non-ischaemic cardiomyopathy towards a more physiological picture of FA uptake which correlates with reverse remodelling. Retained metabolic flexibility may therefore be critical for subsequent reverse remodelling.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39998427/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39998427</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf033>10.1093/eurheartj/ehaf033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39998427</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Peregrine G Green</dc:creator>
<dc:creator>William D Watson</dc:creator>
<dc:creator>Benjamin M Bussmann</dc:creator>
<dc:creator>Giovanni Luigi De Maria</dc:creator>
<dc:creator>Stefan Neubauer</dc:creator>
<dc:creator>Andrew J M Lewis</dc:creator>
<dc:creator>Oliver J Rider</dc:creator>
<dc:creator>Neil Herring</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Metabolic flexibility and reverse remodelling of the failing human heart</dc:title>
<dc:identifier>pmid:39998427</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf033</dc:identifier>
</item>
<item>
<title>Endothelial PPARδ Ablation Exacerbates Vascular Hyperpermeability via STAT1/CXCL10 Signaling in Acute Lung Injury</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39996324/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: These results highlighted a novel anti-inflammatory role of PPARδ in ECs by suppressing CXCL10-mediating vascular hyperpermeability. Targeting the CXCL10 signaling shows therapeutic potential against vascular injury in acute lung injury.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Feb 25. doi: 10.1161/CIRCRESAHA.124.325855. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Vascular hyperpermeability is one of the hallmarks of acute lung injury, contributing to excessive inflammation and respiratory failure. The PPARδ (peroxisome proliferator-activated receptor delta) is an anti-inflammatory transcription factor, although its role in endothelial barrier function remains unclear. Here, we studied the essential role of PPARδ in maintaining vascular endothelial barrier integrity during lung inflammation and investigated the underlying mechanisms.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Endothelial cell (EC)-selective PPARδ knockout mice (Ppard<sup>EC-KO</sup>) and littermate control mice (Ppard<sup>EC-WT</sup>) received lipopolysaccharide injection to induce acute lung injury. Lung inflammation, pulmonary vascular leakage, and mouse mortality were monitored. Single-cell RNA sequencing was performed on sorted mouse lung ECs.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Ppard<sup>EC-KO</sup> mice exhibited aggravated lung inflammation, characterized by increased leukocyte infiltration, elevated production of proinflammatory cytokines, and higher mortality rates. The enhanced inflammatory responses were associated with increased protein leakage, interstitial edema, and impaired endothelial barrier structure, leading to vascular hyperpermeability in Ppard<sup>EC-KO</sup> mice. Mechanistically, with single-cell RNA sequencing, we identified the emergence of an interferon-activated capillary EC population marked by CXCL10 (C-X-C motif chemokine 10) expression following lipopolysaccharide challenge. PPARδ silencing significantly increased CXCL10 expression in ECs through activating STAT1. Notably, CXCL10 treatment induced degradation of tight junction proteins ZO-1 (zonula occluden-1) and claudin-5 through the ubiquitin-proteasome system, disrupting membrane junction continuity in ECs. Administration of anti-CXCL10 antibody or CXCL10 receptor antagonist AMG487 suppressed both lipopolysaccharide-induced lung inflammation and vascular leakage in Ppard<sup>EC-KO</sup> mice.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These results highlighted a novel anti-inflammatory role of PPARδ in ECs by suppressing CXCL10-mediating vascular hyperpermeability. Targeting the CXCL10 signaling shows therapeutic potential against vascular injury in acute lung injury.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39996324/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39996324</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325855>10.1161/CIRCRESAHA.124.325855</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39996324</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Huiling Hong</dc:creator>
<dc:creator>Yalan Wu</dc:creator>
<dc:creator>Yangxian Li</dc:creator>
<dc:creator>Yumeng Han</dc:creator>
<dc:creator>Xiaoyun Cao</dc:creator>
<dc:creator>Vivian Wei Yan Wu</dc:creator>
<dc:creator>Thomas Ting Hei Chan</dc:creator>
<dc:creator>Jingying Zhou</dc:creator>
<dc:creator>Qin Cao</dc:creator>
<dc:creator>Kathy O Lui</dc:creator>
<dc:creator>Chun-Kwok Wong</dc:creator>
<dc:creator>Zhiyu Dai</dc:creator>
<dc:creator>Xiao Yu Tian</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Endothelial PPARδ Ablation Exacerbates Vascular Hyperpermeability via STAT1/CXCL10 Signaling in Acute Lung Injury</dc:title>
<dc:identifier>pmid:39996324</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325855</dc:identifier>
</item>
<item>
<title>ASH2L Deficiency in Smooth Muscle Drives Pulmonary Vascular Remodeling</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39996311/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: This study demonstrated that ASH2L deficiency causatively affects SMC proliferation and lung vascular remodeling that is partially mediated through KLF5-dependent NOTCH3 transcription. Activating ASH2L or targeting KLF5 might represent potential therapeutic strategies for PH.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Feb 25. doi: 10.1161/CIRCRESAHA.124.325539. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Histone H3 lysine 4 methylation is one of the most abundant epigenetic modifications, which has been recently linked to vascular remodeling in pulmonary hypertension (PH). SET1/MLL methyltransferase complexes comprise the main enzymes responsible for methylating H3 lysine 4, yet their roles in vascular remodeling and PH are not fully understood. We aim to assess the contribution of ASH2L, a core SET1/MLL family member, to the pathogenesis of PH.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Human pulmonary artery specimens and primary vascular cells, smooth muscle cell (SMC)-specific ASH2L-deficient mice, rats with SMC-specific ASH2L overexpression, mass spectrometry, immunoprecipitation, and chromatin immunoprecipitation were used to define the role of ASH2L in PH.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Analysis of bulk RNA-sequencing data sets from human lung vessels identified ASH2L as the only differentially expressed SET1/MLL family member in PH compared with healthy controls. Decreased ASH2L expression in human pulmonary arteries correlated with the clinical severity of PH, which contrasted with elevated H3 lysine 4 methylation and was primarily localized to SMCs. Depletion of ASH2L promoted whereas its restoration ameliorated SMC proliferation and vascular remodeling in PH. Mechanistically, we revealed that ASH2L functioned independently of the canonical H3 lysine 4 trimethylation-based transcriptional activation, while it formed a protein complex with KLF5 and FBXW7, thereby accelerating the ubiquitin-proteasomal degradation of KLF5. NOTCH3 was discovered as a new downstream target of KLF5, and the loss of ASH2L promoted the recruitment of KLF5 to the NOTCH3 promoter, thus enhancing NOTCH3 expression. Pharmacological blockage of KLF5 attenuated PH in chronic hypoxia-exposed SMC-specific ASH2L-deficient mice and sugen/hypoxia-challenged rats.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This study demonstrated that ASH2L deficiency causatively affects SMC proliferation and lung vascular remodeling that is partially mediated through KLF5-dependent NOTCH3 transcription. Activating ASH2L or targeting KLF5 might represent potential therapeutic strategies for PH.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39996311/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39996311</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325539>10.1161/CIRCRESAHA.124.325539</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39996311</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Jing Zhang</dc:creator>
<dc:creator>Xia Gu</dc:creator>
<dc:creator>Tian-Le Cheng</dc:creator>
<dc:creator>Yong-Jia Qi</dc:creator>
<dc:creator>Dao-Yan Liu</dc:creator>
<dc:creator>Na Wu</dc:creator>
<dc:creator>Da-Peng Wang</dc:creator>
<dc:creator>Yu Huang</dc:creator>
<dc:creator>Zhi-Ming Zhu</dc:creator>
<dc:creator>Ye Fan</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>ASH2L Deficiency in Smooth Muscle Drives Pulmonary Vascular Remodeling</dc:title>
<dc:identifier>pmid:39996311</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325539</dc:identifier>
</item>
<item>
<title>The year in cardiovascular medicine 2024: the top 10 papers in ischaemic heart disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39995250/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 25:ehaf078. doi: 10.1093/eurheartj/ehaf078. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39995250/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39995250</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf078>10.1093/eurheartj/ehaf078</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39995250</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Diana A Gorog</dc:creator>
<dc:creator>Ranil de Silva</dc:creator>
<dc:creator>William E Boden</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The year in cardiovascular medicine 2024: the top 10 papers in ischaemic heart disease</dc:title>
<dc:identifier>pmid:39995250</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf078</dc:identifier>
</item>
<item>
<title>Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39995248/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 25:ehaf062. doi: 10.1093/eurheartj/ehaf062. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39995248/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39995248</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf062>10.1093/eurheartj/ehaf062</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39995248</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Mahmoud Abdellatif</dc:creator>
<dc:creator>Francisco Vasques-Nóvoa</dc:creator>
<dc:creator>Viktoria Trummer-Herbst</dc:creator>
<dc:creator>Sylvère Durand</dc:creator>
<dc:creator>Franziska Koser</dc:creator>
<dc:creator>Moydul Islam</dc:creator>
<dc:creator>Jihoon Nah</dc:creator>
<dc:creator>Eun-Ah Sung</dc:creator>
<dc:creator>Ruli Feng</dc:creator>
<dc:creator>Fanny Aprahamian</dc:creator>
<dc:creator>Andreas Prokesch</dc:creator>
<dc:creator>Pablo Zardoya-Laguardia</dc:creator>
<dc:creator>Junichi Sadoshima</dc:creator>
<dc:creator>Abhinav Diwan</dc:creator>
<dc:creator>Wolfgang A Linke</dc:creator>
<dc:creator>João Pedro Ferreira</dc:creator>
<dc:creator>Guido Kroemer</dc:creator>
<dc:creator>Simon Sedej</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction</dc:title>
<dc:identifier>pmid:39995248</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf062</dc:identifier>
</item>
<item>
<title>Digital Twins: The Future for Ventricular Tachycardia Ablation?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993042/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):534-536. doi: 10.1161/CIRCULATIONAHA.124.072299. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993042/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39993042</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072299>10.1161/CIRCULATIONAHA.124.072299</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993042</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Dingxin Qin</dc:creator>
<dc:creator>Jagmeet P Singh</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Digital Twins: The Future for Ventricular Tachycardia Ablation?</dc:title>
<dc:identifier>pmid:39993042</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072299</dc:identifier>
</item>
<item>
<title>Correction to: Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993041/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):e677-e679. doi: 10.1161/CIR.0000000000001313. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993041/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39993041</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001313>10.1161/CIR.0000000000001313</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993041</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:39993041</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001313</dc:identifier>
</item>
<item>
<title>CXCL12 Derived From ACKR1&lt;sup>;+&lt;/sup>; Intraplaque Neovessels Mediates CD8&lt;sup>;+&lt;/sup>; T Cell Recruitment in Human Atherosclerosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993040/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):581-584. doi: 10.1161/CIRCULATIONAHA.124.072560. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993040/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39993040</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072560>10.1161/CIRCULATIONAHA.124.072560</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993040</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Laura Parma</dc:creator>
<dc:creator>Nadja Sachs</dc:creator>
<dc:creator>Nikola Sobczak</dc:creator>
<dc:creator>Zhaolong Li</dc:creator>
<dc:creator>Kevin Merchant</dc:creator>
<dc:creator>Jessica Pauli</dc:creator>
<dc:creator>Marie A C Depuydt</dc:creator>
<dc:creator>Anouk Wezel</dc:creator>
<dc:creator>Harm J Smeets</dc:creator>
<dc:creator>Ilze Bot</dc:creator>
<dc:creator>Bram Slütter</dc:creator>
<dc:creator>Lars Maegdefessel</dc:creator>
<dc:creator>Christian Weber</dc:creator>
<dc:creator>Johan Duchêne</dc:creator>
<dc:creator>Remco T A Megens</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>CXCL12 Derived From ACKR1&lt;sup>;+&lt;/sup>; Intraplaque Neovessels Mediates CD8&lt;sup>;+&lt;/sup>; T Cell Recruitment in Human Atherosclerosis</dc:title>
<dc:identifier>pmid:39993040</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072560</dc:identifier>
</item>
<item>
<title>New Stroke Awareness Campaign Focuses on Hispanic and Latino People: Culturally Relevant and Spanish-Language Resources Aim to Improve Health Knowledge and Equity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993039/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):566-567. doi: 10.1161/CIRCULATIONAHA.124.073068. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993039/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39993039</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073068>10.1161/CIRCULATIONAHA.124.073068</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993039</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Bridget M Kuehn</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>New Stroke Awareness Campaign Focuses on Hispanic and Latino People: Culturally Relevant and Spanish-Language Resources Aim to Improve Health Knowledge and Equity</dc:title>
<dc:identifier>pmid:39993039</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.073068</dc:identifier>
</item>
<item>
<title>New Definition of Elevated Blood Pressure in the 2024 ESC Guidelines: Increased Prevalence, Uncertain Evidence</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993038/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):518-520. doi: 10.1161/CIRCULATIONAHA.124.072696. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993038/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39993038</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072696>10.1161/CIRCULATIONAHA.124.072696</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993038</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Emmanuelle Vidal-Petiot</dc:creator>
<dc:creator>Sofiane Kab</dc:creator>
<dc:creator>Philippe Gabriel Steg</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>New Definition of Elevated Blood Pressure in the 2024 ESC Guidelines: Increased Prevalence, Uncertain Evidence</dc:title>
<dc:identifier>pmid:39993038</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072696</dc:identifier>
</item>
<item>
<title>Malignant ST-Segment-Elevation in a Young Man With Syncope: Important Clues Hidden in Diagnostic Traps</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993037/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):574-577. doi: 10.1161/CIRCULATIONAHA.124.073499. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993037/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39993037</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073499>10.1161/CIRCULATIONAHA.124.073499</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993037</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Xi Huang</dc:creator>
<dc:creator>Yubin Zhang</dc:creator>
<dc:creator>Ren Yan</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Malignant ST-Segment-Elevation in a Young Man With Syncope: Important Clues Hidden in Diagnostic Traps</dc:title>
<dc:identifier>pmid:39993037</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.073499</dc:identifier>
</item>
<item>
<title>Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993036/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):e681. doi: 10.1161/CIR.0000000000001312. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993036/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39993036</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001312>10.1161/CIR.0000000000001312</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993036</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017</dc:title>
<dc:identifier>pmid:39993036</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001312</dc:identifier>
</item>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993035/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):568-573. doi: 10.1161/CIRCULATIONAHA.125.073856. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993035/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39993035</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.073856>10.1161/CIRCULATIONAHA.125.073856</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993035</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:39993035</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.073856</dc:identifier>
</item>
<item>
<title>Correction to: Abstract 4139303: Temporal Trends in Cardiovascular Risk Factors and Cardiovascular Disease among Middle Eastern Immigrants in the National Health Interview Survey 2004-2018</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993034/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):e680. doi: 10.1161/CIR.0000000000001311. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993034/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39993034</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001311>10.1161/CIR.0000000000001311</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993034</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Abstract 4139303: Temporal Trends in Cardiovascular Risk Factors and Cardiovascular Disease among Middle Eastern Immigrants in the National Health Interview Survey 2004-2018</dc:title>
<dc:identifier>pmid:39993034</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001311</dc:identifier>
</item>
<item>
<title>Coronary CT Anatomy-Based Prediction of Invasively Assessed Hemodynamic Significance in Middle-Aged Patients With Right Coronary Artery Anomaly: The NARCO Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993033/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):578-580. doi: 10.1161/CIRCULATIONAHA.124.071637. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993033/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39993033</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071637>10.1161/CIRCULATIONAHA.124.071637</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993033</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Anselm W Stark</dc:creator>
<dc:creator>René L Matthey-de-l'Endroit</dc:creator>
<dc:creator>Adriana Ferroni</dc:creator>
<dc:creator>Ryota Kakizaki</dc:creator>
<dc:creator>Marius R Bigler</dc:creator>
<dc:creator>Flavio G Biccirè</dc:creator>
<dc:creator>Yasushi Ueki</dc:creator>
<dc:creator>Andreas Haeberlin</dc:creator>
<dc:creator>Matthias Siepe</dc:creator>
<dc:creator>Isaac Shiri</dc:creator>
<dc:creator>Stephan Windecker</dc:creator>
<dc:creator>Lorenz Räber</dc:creator>
<dc:creator>Christoph Gräni</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Coronary CT Anatomy-Based Prediction of Invasively Assessed Hemodynamic Significance in Middle-Aged Patients With Right Coronary Artery Anomaly: The NARCO Study</dc:title>
<dc:identifier>pmid:39993033</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071637</dc:identifier>
</item>
<item>
<title>Artificial intelligence applied to electrocardiogram to rule out acute myocardial infarction: the ROMIAE multicentre study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39992309/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In this multicentre prospective study, the AI-ECG demonstrated diagnostic accuracy and predictive power for AMI and 30 day MACE, which was similar to or better than that of traditional risk stratification methods and ED physicians.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 24:ehaf004. doi: 10.1093/eurheartj/ehaf004. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Emerging evidence supports artificial intelligence-enhanced electrocardiogram (AI-ECG) for detecting acute myocardial infarction (AMI), but real-world validation is needed. The aim of this study was to evaluate the performance of AI-ECG in detecting AMI in the emergency department (ED).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The Rule-Out acute Myocardial Infarction using Artificial intelligence Electrocardiogram analysis (ROMIAE) study is a prospective cohort study conducted in the Republic of Korea from March 2022 to October 2023, involving 18 university-level teaching hospitals. Adult patients presenting to the ED within 24 h of symptom onset concerning for AMI were assessed. Exposure included AI-ECG score, HEART score, GRACE 2.0 score, high-sensitivity troponin level, and Physician AMI score. The primary outcome was diagnosis of AMI during index admission, and the secondary outcome was 30 day major adverse cardiovascular event (MACE).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The study population comprised 8493 adults, of whom 1586 (18.6%) were diagnosed with AMI. The area under the receiver operating characteristic curve for AI-ECG was 0.878 (95% CI, 0.868-0.888), comparable with the HEART score (0.877; 95% CI, 0.869-0.886) and superior to the GRACE 2.0 score, high-sensitivity troponin level, and Physician AMI score. For predicting 30 day MACE, AI-ECG (area under the receiver operating characteristic, 0.866; 95% CI, 0.856-0.877) performed comparably with the HEART score (0.858; 95% CI, 0.848-0.868). The integration of the AI-ECG improved risk stratification and AMI discrimination, with a net reclassification improvement of 19.6% (95% CI, 17.38-21.89) and a C-index of 0.926 (95% CI, 0.919-0.933), compared with the HEART score alone.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In this multicentre prospective study, the AI-ECG demonstrated diagnostic accuracy and predictive power for AMI and 30 day MACE, which was similar to or better than that of traditional risk stratification methods and ED physicians.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39992309/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39992309</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf004>10.1093/eurheartj/ehaf004</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39992309</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Min Sung Lee</dc:creator>
<dc:creator>Tae Gun Shin</dc:creator>
<dc:creator>Youngjoo Lee</dc:creator>
<dc:creator>Dong Hoon Kim</dc:creator>
<dc:creator>Sung Hyuk Choi</dc:creator>
<dc:creator>Hanjin Cho</dc:creator>
<dc:creator>Mi Jin Lee</dc:creator>
<dc:creator>Ki Young Jeong</dc:creator>
<dc:creator>Won Young Kim</dc:creator>
<dc:creator>Young Gi Min</dc:creator>
<dc:creator>Chul Han</dc:creator>
<dc:creator>Jae Chol Yoon</dc:creator>
<dc:creator>Eujene Jung</dc:creator>
<dc:creator>Woo Jeong Kim</dc:creator>
<dc:creator>Chiwon Ahn</dc:creator>
<dc:creator>Jeong Yeol Seo</dc:creator>
<dc:creator>Tae Ho Lim</dc:creator>
<dc:creator>Jae Seong Kim</dc:creator>
<dc:creator>Jeff Choi</dc:creator>
<dc:creator>Joon-Myoung Kwon</dc:creator>
<dc:creator>Kyuseok Kim</dc:creator>
<dc:creator>ROMIAE study group</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Artificial intelligence applied to electrocardiogram to rule out acute myocardial infarction: the ROMIAE multicentre study</dc:title>
<dc:identifier>pmid:39992309</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf004</dc:identifier>
</item>
<item>
<title>Sex-specific pathways from vascular ageing to cardiac damage: unfavourable pulse pressure trajectories induce atrial fibrillation in women</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39991783/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 24:ehaf039. doi: 10.1093/eurheartj/ehaf039. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39991783/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39991783</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf039>10.1093/eurheartj/ehaf039</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39991783</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Rosa Maria Bruno</dc:creator>
<dc:creator>Emmanuelle Vidal Petiot</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Sex-specific pathways from vascular ageing to cardiac damage: unfavourable pulse pressure trajectories induce atrial fibrillation in women</dc:title>
<dc:identifier>pmid:39991783</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf039</dc:identifier>
</item>
<item>
<title>Left Ventricular Entry to Reduce Brain Lesions During Catheter Ablation: A Randomized Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39989365/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Among patients undergoing left ventricular catheter ablation procedures, a transseptal approach reduced the risk of acute brain lesions by nearly half compared with a retrograde aortic approach without sacrificing safety or efficacy. Given a likely embolic pathogenesis, the brain magnetic resonance imaging findings may reflect a propensity to other organ damage; these findings may extend to other procedures requiring left ventricular entry.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 24. doi: 10.1161/CIRCULATIONAHA.124.071352. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Catheter ablation of ventricular arrhythmias, one of the most rapidly growing procedures in cardiac electrophysiology, is associated with magnetic resonance imaging-detected brain lesions in more than half of cases. Although a retrograde aortic approach is conventional, modern tools enable entry through a transseptal approach that may avoid embolization of debris from the arterial system. We sought to test the hypothesis that a transseptal puncture would mitigate brain injury compared with a retrograde aortic approach.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The TRAVERSE trial (Transseptal Versus Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli) was a multicenter randomized controlled comparative effectiveness trial. Patients with left ventricular arrhythmias undergoing catheter ablation procedures were randomly assigned to a transseptal puncture approach compared (1:1) with a retrograde aortic approach. The primary outcome was the presence of an acute brain lesion detected by magnetic resonance imaging. Secondary outcomes included clinically manifest complications, procedural efficacy, and 6-month neurocognitive assessments.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among the 62 patients randomly assigned to a retrograde aortic approach with postoperative brain magnetic resonance imaging, 28 (45%) exhibited an acute brain lesion compared with 19 of the 69 (28%) of those randomized to a transseptal puncture (<i>P</i>=0.036). No differences in clinically manifest complications or procedural efficacy were observed. More patients in the retrograde aortic arm were categorized as having a high likelihood of cognitive impairment at 6 months (33% compared with 19% of those in the transseptal arm), but substantial loss to follow-up was present.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Among patients undergoing left ventricular catheter ablation procedures, a transseptal approach reduced the risk of acute brain lesions by nearly half compared with a retrograde aortic approach without sacrificing safety or efficacy. Given a likely embolic pathogenesis, the brain magnetic resonance imaging findings may reflect a propensity to other organ damage; these findings may extend to other procedures requiring left ventricular entry.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03946072.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39989365/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39989365</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071352>10.1161/CIRCULATIONAHA.124.071352</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39989365</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Gregory M Marcus</dc:creator>
<dc:creator>Roderick Tung</dc:creator>
<dc:creator>Edward P Gerstenfeld</dc:creator>
<dc:creator>Trisha F Hue</dc:creator>
<dc:creator>Feng Lin</dc:creator>
<dc:creator>Jing Cheng</dc:creator>
<dc:creator>J Peter Weiss</dc:creator>
<dc:creator>Wendy S Tzou</dc:creator>
<dc:creator>Henry Hsia</dc:creator>
<dc:creator>Ashkan Ehdaie</dc:creator>
<dc:creator>Daniel H Cooper</dc:creator>
<dc:creator>T Jared Bunch</dc:creator>
<dc:creator>Jeffrey Arkles</dc:creator>
<dc:creator>Babak Nazer</dc:creator>
<dc:creator>Adam Lee</dc:creator>
<dc:creator>Alexios Hadjis</dc:creator>
<dc:creator>Duy T Nguyen</dc:creator>
<dc:creator>Mihail G Chelu</dc:creator>
<dc:creator>Joshua Moss</dc:creator>
<dc:creator>Jonathan C Hsu</dc:creator>
<dc:creator>Miguel Valderrábano</dc:creator>
<dc:creator>Prashant D Bhave</dc:creator>
<dc:creator>Andrew D Beaser</dc:creator>
<dc:creator>Arvindh Kanagasundram</dc:creator>
<dc:creator>Oussama Wazni</dc:creator>
<dc:creator>Jason Bradfield</dc:creator>
<dc:creator>Grace Wall</dc:creator>
<dc:creator>Kathleen Chang</dc:creator>
<dc:creator>Michelle Yang</dc:creator>
<dc:creator>Gabrielle Montenegro</dc:creator>
<dc:creator>Sabrina Jarrott</dc:creator>
<dc:creator>Joel H Kramer</dc:creator>
<dc:creator>Anthony S Kim</dc:creator>
<dc:creator>Yvonne M Morris</dc:creator>
<dc:creator>William P Dillon</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Left Ventricular Entry to Reduce Brain Lesions During Catheter Ablation: A Randomized Trial</dc:title>
<dc:identifier>pmid:39989365</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071352</dc:identifier>
</item>
<item>
<title>Aortic Valve Calcification Is Induced by the Loss of ALDH1A1 and Can Be Prevented by Agonists of Retinoic Acid Receptor Alpha: Preclinical Evidence for Drug Repositioning</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39989358/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226111405&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: These results show that ALDH1A1 is downregulated in calcified valves, hence promoting VIC transition into an osteoblastic phenotype. Retinoic acid receptor alpha agonists, including all-trans retinoic acid through a drug repositioning strategy, represent a promising and innovative pharmacological approach to prevent calcification of native aortic valves and BPV.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 24. doi: 10.1161/CIRCULATIONAHA.124.071954. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: To date, the only effective treatment of severe aortic stenosis is valve replacement. With the introduction of transcatheter aortic valve replacement and extending indications to younger patients, the use of bioprosthetic valves (BPVs) has considerably increased. The main inconvenience of BPVs is their limited durability because of mechanisms similar as the fibro-calcifying processes observed in native aortic stenosis. One of the major gaps of the field is to identify therapeutic targets to prevent or slow the fibro-calcifying process leading to severe and symptomatic aortic stenosis. The aim was to identify new targets for anticalcification drugs to prevent aortic and BPV calcification using an unbiased translational approach.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Explanted valves were collected from patients and organ donor hearts. A comparative transcriptomic analysis was performed on valvular interstitial cells (VIC) obtained from calcified (bicuspid and tricuspid) versus control valves. The mechanisms and consequences of aldehyde dehydrogenase 1 family member A1 (ALDH1A1) downregulation were analyzed in VIC cultures from control human aortic valves. ALDH1A1 was inhibited or silenced and its impact on osteogenic marker expression and calcification processes assessed in VIC. The effect of all-trans retinoic acid on calcification was tested on human VIC cultures and on 2 animal models: the model of subcutaneous implantation of bovine pericardium in rats and the model of xenograft aortic valve replacement in juvenile sheep.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Transcriptome analysis of human VIC identified ALDHA1 as the most downregulated gene in VIC from calcified versus control valves. In human VIC, ALDH1A1 expression is downregulated by TGF-β1 in a SMAD2/3-dependent manner. ALDH1A1 inhibition promotes an osteoblast-like VIC phenotype and increases calcium deposition through inhibition of retinoic acid receptor alpha signaling. Conversely, VIC treatment with retinoids decreases calcium deposition and attenuates VIC osteoblast activity. Last, all-trans retinoic acid inhibits calcification development of aortic BPV in both in vivo models and improves aortic valve echocardiographic parameters in the xenograft sheep model.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These results show that ALDH1A1 is downregulated in calcified valves, hence promoting VIC transition into an osteoblastic phenotype. Retinoic acid receptor alpha agonists, including all-trans retinoic acid through a drug repositioning strategy, represent a promising and innovative pharmacological approach to prevent calcification of native aortic valves and BPV.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39989358/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226111405&v=2.18.0.post9+e462414">39989358</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071954>10.1161/CIRCULATIONAHA.124.071954</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39989358</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Mickael Rosa</dc:creator>
<dc:creator>Annabelle Dupont</dc:creator>
<dc:creator>David M Smadja</dc:creator>
<dc:creator>Jérôme Soquet</dc:creator>
<dc:creator>Johan Abdoul</dc:creator>
<dc:creator>Thibault Pamart</dc:creator>
<dc:creator>Flavien Vincent</dc:creator>
<dc:creator>Christina Le Tanno</dc:creator>
<dc:creator>Eloise Borowczac</dc:creator>
<dc:creator>Timothée Bigot</dc:creator>
<dc:creator>Alexandre Ung</dc:creator>
<dc:creator>Bertrand Vaast</dc:creator>
<dc:creator>Mélanie Daniel</dc:creator>
<dc:creator>Ramadan Jashari</dc:creator>
<dc:creator>Frédéric Mouquet</dc:creator>
<dc:creator>Cedric Delhaye</dc:creator>
<dc:creator>Yoann Sottejeau</dc:creator>
<dc:creator>Jeanne Rancic</dc:creator>
<dc:creator>Delphine Corseaux</dc:creator>
<dc:creator>Francis Juthier</dc:creator>
<dc:creator>Bart Staels</dc:creator>
<dc:creator>Sophie Susen</dc:creator>
<dc:creator>Eric Van Belle</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Aortic Valve Calcification Is Induced by the Loss of ALDH1A1 and Can Be Prevented by Agonists of Retinoic Acid Receptor Alpha: Preclinical Evidence for Drug Repositioning</dc:title>
<dc:identifier>pmid:39989358</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071954</dc:identifier>
</item>





























</channel>
</rss>